Last October, Laurie Parker (Purdue University) and David applied for an NIH grant to study site specific tyrosine phosphorylation of EGFR and of ErbB4.  The reviews of this grant application are now available.  Overall, this application received positive reviews.  Nonetheless, the application did not receive a priority score that is likely to result in funding.